comparemela.com

Latest Breaking News On - Sickle cell disease - Page 11 : comparemela.com

Transcripts For CSPAN3 House Appropriations Hearing On NIH Research 20240713

Being late. The days take on a life of their own. So, but i wanted to say good morning. Good morning, dr. Collins, welcome back to labor hhs to the appropriations subcommittee. Let me just say a thank you on behalf of the of the subcommittee for hosting members of the subcommittee for the site visit at the nih campus last week. We had a wonderful opportunity to learn more about nihs work. We met with the researchers who were working to cure Sickle Cell Disease, to develop treatments for major depression, the shrinkage of cancer tumors in children. We heard from participants whose lives have been changed by Clinical Trials. So it was a moving and an informative, but a very moving experience, as well. Let me welcome our witnesses including the five institute and Center Directors who join us today, and in addition, and always a great addition dr. Francis collins who has joined us many times, director of the National Institutes of health. Today joined by dr. Bruce tromberg, by the institut

New-york
United-states
Puerto-rico
Oklahoma
Washington
Boston
Massachusetts
New-mexico
France
Cincinnati
Ohio
Connecticut

Transcripts For CSPAN3 House Appropriations Hearing On NIH Research 20240713

Testified before the House Appropriations subcommittee on funding and research efforts. This is about two and a half hours. The subcommittee will come to order. Thank you all very much and we apologize for being late. They his take on a life of their own. I wanted to say good morning and welcome back to labor the appropriations subcommittee. Let me just say thank you on the behalf of the subcommittee for hosting members of the subcommittee for this site visit. Thats the nih campus last week. We had a wonderful opportunity to learn about nih is outwork. We met with a who are working to cure Sickle Cell Disease and develop treatment for major depressions and shrink cancer tumors in children. We heard from participants whose lives have been changed by Clinical Trials it wasnt informative moving experience as well. And we welcome our witnesses including the five institute senator actors returns today. And in addition and always a great addition doctor Francis Collins who has joined us many

China
California
United-states
Oklahoma
London
City-of
United-kingdom
Americans
American
Rosa-delauro
Francis-collins
Tom-cole

Transcripts For CSPAN3 House Appropriations Hearing On NIH Research 20240713

Testified before the House Appropriations subcommittee on funding and research efforts. This is about two and a half hours. The subcommittee will come to order. Thank you all very much and we apologize for being late. They his take on a life of their own. I wanted to say good morning and welcome back to labor the appropriations subcommittee. Let me just say thank you on the behalf of the subcommittee for hosting members of the subcommittee for this site visit. Thats the nih campus last week. We had a wonderful opportunity to learn about nih is outwork. We met with a who are working to cure Sickle Cell Disease and develop treatment for major depressions and shrink cancer tumors in children. We heard from participants whose lives have been changed by Clinical Trials it wasnt informative moving experience as well. And we welcome our witnesses including the five institute senator actors returns today. And in addition and always a great addition doctor Francis Collins who has joined us many

China
California
United-states
Oklahoma
London
City-of
United-kingdom
Americans
American
Rosa-delauro
Francis-collins
Tom-cole

Transcripts For CSPAN U.S. House Of Representatives U.S. House Of Representatives 20240714

The speaker the house will be in order. The prayer will be offered by our chaplain, father conroy. Chaplain conroy let us pray. Eternal father, thank you for giving us another day. The house is eptering a two week recess, many members will be returning to their districts to meet with constituents. We know that work will be getting done behind the overt political scene. While important and significant issues are being addressed, may all members be imbued with the wisdom of solomon, the patience of job, and proceed like nathaniel who was a man without guile. In all, let there be more light than heat. May all that is done be for your greater honor and glory. Men. The speaker the chair has examined the journal of the last days proceedings and announces to the house her pproval thereof. Pursuant to clause 1 of rule 1, the journal stands approved. For what purpose does the the gentlewoman from california seek recognition . Thank you, madam speaker. Pursuant to clause 1 of rule 1, i demand a

Jerusalem
Israel-general-
Israel
Louisiana
United-states
Alabama
Alaska
Vermont
Boulder-county
Colorado
Brazil
Delaware

Transcripts For CSPAN3 House Appropriations Hearing On NIH Research 20240713

The subcommittee will come to order. Thank you all very, very much and, again, we apologize for being late. Days take on a life of their own. But i wanted to say good morning, dr. Collins. Welcome back to labor hhs, the appropriations subcommittee. Let me just say thank you on behalf of the of the subcommittee for hosting members of the subcommittee for the site visit at the nih campus last week. We had a wonderful opportunity to learn more about nihs work. We met with the researchers who were working to cure Sickle Cell Disease, to develop treatments for major depression, shrink and treat cancer tumors in children. We heard from participants whose lives have been changed by Clinical Trials. So it was a moving an informative but a very moving experience as well. Let me welcome our witnesses, including the five institute and Center Directors who join us today and in addition, and always a great addition, dr. Francis collins whos joined us many times, director of the National Institutes

New-york
United-states
Puerto-rico
Oklahoma
Rome
Lazio
Italy
Alaska
Washington
Boston
Massachusetts
Whitehouse

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.